-
Loading metrics
Routine Primary Prophylaxis for Febrile Neutropenia with Biosimilar Granulocyte Colony-Stimulating Factor (Nivestim) or Pegfilgrastim Is Cost Effective in Non-Hodgkin Lymphoma Patients undergoing Curative-Intent R-CHOP Chemotherapy
- Xiao Jun Wang,
- Tiffany Tang,
- Mohamad Farid,
- Richard Quek,
- Miriam Tao,
- Soon Thye Lim,
- Hwee Lin Wee,
- Alexandre Chan
x
- Published: February 12, 2016
- https://doi.org/10.1371/journal.pone.0148901